Biology of Blood and Marrow Transplantation
Volume 15, Issue 11 , Pages 1439-1446, November 2009

Early and Late Neurological Complications after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation

  • Pere Barba

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
  • ,
  • Jose Luis Piñana

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
    • Corresponding Author InformationCorrespondence and reprint requests: Jose Luis Piñana, Hematology Department, Hospital de la Santa Creu i Sant Pau, St. Antoni Maria I Claret 167, Barcelona 08021, Spain.
  • ,
  • David Valcárcel

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
  • ,
  • Luis Querol

      Affiliations

    • Neurology Department, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
  • ,
  • Rodrigo Martino

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
  • ,
  • Anna Sureda

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
  • ,
  • Javier Briones

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
  • ,
  • Julio Delgado

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
  • ,
  • Salut Brunet

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain
  • ,
  • Jorge Sierra

      Affiliations

    • Hematology Department and Stem Cell Transplantation Program, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Spain

Received 28 April 2009; accepted 11 July 2009. published online 02 September 2009.

Neurological complications (NC) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) are common and life-threatening in most cases. They may involve either the central (CNS) or peripheral nervous system (PNS). The aim of this study was to describe incidence and characteristics of NC after reduced-intensity conditioning allo-HSCT (allo-RIC), an unexplored setting. For this purpose, we reviewed 191 consecutive patients who underwent this procedure at our institution between January 1999 and December 2006. The median follow-up for survivors was 48 months (3-98 months). RIC included fludarabine (Flu) 150mg/m2 in combination with busulfan (Bu) 8-10mg/kg (n=61), melphalan (Mel) 70-140mg/m2 (n=119), cyclophosphamide (Cy) 120mg/kg (n=7), or low-dose total body irradiation (TBI) 2Gy (n=4). Graft-versus-host disease (GVHD) prophylaxis consisted of cyclosporine A (CsA) in combination with methotrexate (MTX; n=134) or mycophenolate mofetil (MMF; n=52). Twenty-seven patients (14%) developed a total of 31 NC (23 CNS and 8 PNS) for a 4-year cumulative incidence of 16% (95% confidence interval [CI] 11-23). CNS complications included nonfocal encephalopathies in 11 patients, meningoencephalitis in 5 patients, and stroke or hemorrhage in 4. PNS complications consisted of 5 cases of mononeuropathies and 3 cases of polyneuropathies. Drug-related toxicity was responsible for 10 of the 31 events (32%) (8 caused by CsA). Interestingly, 14 of the 23 CNS events (61%) and only 1 of the 8 PNS complications (13%) appeared before day +100 (P=.01). Overall, patients presenting NC showed a trend for higher 1-year nonrelapse mortality (NRM) (37% versus 20%, P=.08). In patients with CNS involvement, 1-year NRM was significantly worse (42% versus 20%, P=.02). CNS NC also had a negative impact on 4-year overall survival (OS; 33% versus 45%, P=.05). In conclusion, our study showed that NC are observed after allo-RIC and have diverse features. NC affecting the CNS have earlier onset and worse outcome than those involving the PNS.

Key Words: Neurologic complications, Neurology, Stem cell transplantation, Reduced-intensity conditioning, CNS complications, RIC

 

 Financial disclosure: See Acknowledgments on page 1445.

PII: S1083-8791(09)00342-5

doi:10.1016/j.bbmt.2009.07.013

Biology of Blood and Marrow Transplantation
Volume 15, Issue 11 , Pages 1439-1446, November 2009